MDQ Bipolar Screening
Answer 15 questions from the validated MDQ to screen for bipolar disorder symptoms and get an interpreted score.
Use the MDQ Bipolar Screening
Part 1 — Lifetime Mood Symptoms
Has there ever been a period of time when you were not your usual self and...
Part 2 — Same Time Period
If you checked YES to more than one of the above, did several of these experiences occur during the same period of time?
Part 3 — Functional Impact
How much of a problem did any of these cause you — such as being unable to work; having family, money, or legal trouble; getting into arguments or fights?
Complete all three parts
and click Calculate to see your result.
symptoms
period
impact
This screening tool is not a diagnostic instrument. A positive result should be discussed with a qualified mental health professional.
Summary
The Mood Disorder Questionnaire (MDQ) is a validated self-report screening instrument for bipolar spectrum disorders, developed by Hirschfeld et al. (2000). It asks about 13 lifetime mood-related experiences, whether multiple symptoms occurred in the same time period, and the functional impact of those symptoms. A positive screen (7+ symptoms, same-period clustering, and moderate-to-severe impairment) warrants clinical follow-up. This tool does not diagnose — it flags cases that should be evaluated by a clinician.
How it works
- Read each of the 13 symptom questions and check "Yes" for any that have applied to you at some point in your life.
- Indicate whether several of these experiences occurred during the same period of time.
- Rate the level of difficulty those experiences caused in daily functioning.
- The tool counts your "Yes" responses and applies the three-part MDQ scoring rule.
- Your result shows whether the screen is positive or negative, with an explanation of what that means.
Use cases
- Understand whether your mood history warrants talking to a mental health professional.
- Complete before a psychiatric evaluation to give your clinician structured baseline data.
- Screen for bipolar spectrum symptoms that may have been previously attributed to depression alone.
- Differentiate between unipolar and bipolar presentations in educational or clinical training contexts.
- Support shared decision-making between patients and prescribers about mood stabilizer evaluation.